Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotechnology company advancing targeted antitumor virotherapies, will host an invest ...

Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotechnology company specializing in targeted antitumor virotherapies, reported a ca ...

Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA ...

1Division of Neuro-Oncology, Brain Tumor Center, Keck School of Medicine of University of Southern California, Los Angeles, California.

For the new therapy, these cells are derived from stem cells that originated from healthy adult donor tissue—called induced pluripotent stem cells (iPSCs)—to make therapeutic CAR-NK cells.

The Online STEM Challenge is a four-day hybrid programme designed to give participants the opportunity to apply their STEM knowledge to solve a real world problem. Focused on how different STEM ...

If you have CML that’s advancing despite being on targeted oral medication or is diagnosed in the accelerated or blast phases, your doctors may recommend a stem cell transplant. A stem cell transplant ...

In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are ...

Detailed price information for Calidi Biotherapeutics Inc (CLDI-A) from The Globe and Mail including charting and trades.

UCSF scientists have discovered a new type of stem cell that helps young brains grow but is also capable of forming the cells found in tumors. The breakthrough could explain how adult brain cells take ...